Hippocalcin Is Required for Astrocytic Differentiation through Activation of Stat3 in Hippocampal Neural Precursor Cells by Min-Jeong Kang et al.
fnmol-09-00110 October 26, 2016 Time: 13:44 # 1
ORIGINAL RESEARCH
















Received: 17 August 2016
Accepted: 13 October 2016
Published: 28 October 2016
Citation:
Kang M-J, Park S-Y and Han J-S
(2016) Hippocalcin Is Required for
Astrocytic Differentiation through
Activation of Stat3 in Hippocampal
Neural Precursor Cells.
Front. Mol. Neurosci. 9:110.
doi: 10.3389/fnmol.2016.00110
Hippocalcin Is Required for
Astrocytic Differentiation through
Activation of Stat3 in Hippocampal
Neural Precursor Cells
Min-Jeong Kang1, Shin-Young Park2* and Joong-Soo Han1,2*
1 Department of Biomedical Sciences, Graduate School of Biomedical Science and Engineering, Hanyang University, Seoul,
South Korea, 2 Department of Biochemistry and Molecular Biology, Biomedical Research Institute, College of Medicine,
Hanyang University, Seoul, South Korea
Hippocalcin (Hpca) is a neuronal calcium sensor protein expressed in the mammalian
brain. However, its function in neural stem/precursor cells has not yet been studied.
Here, we clarify the function of Hpca in astrocytic differentiation in hippocampal neural
precursor cells (HNPCs). When we overexpressed Hpca in HNPCs in the presence or
absence of bFGF, expression levels of nerve-growth factors such as neurotrophin-3 (NT-
3), neurotrophin-4/5 (NT-4/5), and brain-derived neurotrophic factor (BDNF), together
with the proneural basic helix loop helix (bHLH) transcription factors NeuroD and
neurogenin 1 (Ngn1), increased significantly. In addition, there was an increase in the
number of cells expressing glial fibrillary acidic protein (GFAP), an astrocyte marker, and
in branch outgrowth, indicating astrocytic differentiation of the HNPCs. Downregulation
of Hpca by transfection with Hpca siRNA reduced expression of NT-3, NT-4/5, BDNF,
NeuroD, and Ngn1 as well as levels of GFAP protein. Furthermore, overexpression of
Hpca increased the phosphorylation of STAT3 (Ser727), and this effect was abolished by
treatment with a STAT3 inhibitor (S3I-201), suggesting that STAT3 (Ser727) activation is
involved in Hpca-mediated astrocytic differentiation. As expected, treatment with Stat3
siRNA or STAT3 inhibitor caused a complete inhibition of astrogliogenesis induced by
Hpca overexpression. Taken together, this is the first report to show that Hpca, acting
through Stat3, has an important role in the expression of neurotrophins and proneural
bHLH transcription factors, and that it is an essential regulator of astrocytic differentiation
and branch outgrowth in HNPCs.
Keywords: hippocalcin (Hpca), hippocampal neural precursor cells, astrocyte, differentiation, signal transducer
and activation of transcription 3 (STAT3)
INTRODUCTION
Neurons, astrocytes, and oligodendrocytes are generated from precursor cells in the
neuroepithelium during development of the central nervous system (CNS) (McKay, 1997;
Gage, 2000; Anderson, 2001; Merkle and Alvarez-Buylla, 2006). In the mouse cerebral cortex,
neurogenesis commences around embryonic day (E) 11, peaks at around E15, and finishes around
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birth. While cortical astrocytes are first apparent at E16 and
oligodendrocytes are present around birth, the vast majority of
both cell types are produced during early neonatal development
(McConnell, 1995; Qian et al., 2000). Although the separate
timing of neurogenesis and gliogenesis in the CNS has been
known for many years, several key questions remain to
be addressed regarding the processes by which precursors
differentiate into the distinct cell types.
Hippocalcin (Hpca) is a calcium-binding protein mostly
found in pyramidal cells of the hippocampus (Saitoh et al.,
1993; Palmer et al., 2005; Amici et al., 2009). It belongs
to the family of EF-hand-containing neuronal calcium sensor
(NCS) proteins that possess a Ca2+/myristoyl switch allowing
translocation to membranes in response to increased cytosolic
Ca2+ concentration (Kobayashi et al., 1993; Braunewell and
Gundelfinger, 1999; O’Callaghan et al., 2002; O’Callaghan et al.,
2003; Aravind et al., 2008). In neuronal cells, Hpca is localized
in the cytoplasm and plasma membrane of cell bodies and
dendrites (Saitoh et al., 1993). We previously reported that
it is involved in the PKC-independent Ca2+-mediated PLD
activation pathway (Hyun et al., 2000) and plays a key role
in basic fibroblast growth factor (bFGF)-induced expression
of NeuroD, leading to neurite outgrowth in H19-7 cells (Oh
et al., 2008). However, the precise mechanism by which
Hpca affects neurogenic or astrogenic potential has not been
studied.
The neurotrophins comprise a family of four structurally
related proteins; nerve growth factor (NGF), brain-derived
neurotrophic factor (BDNF), neurotrophin-3 (NT-3), and
neurotrophin-4 (NT-4) that exert their effects through high-
affinity tyrosine kinase receptors (Trk receptors) (McAllister
et al., 1999; Huang and Reichardt, 2001; Chao, 2003).
Both the neurotrophins and their receptors are most highly
expressed in the developing nervous system during active
neuronal growth and differentiation (McAllister et al., 1999).
In some cell lines, the relative levels of BDNF and NT-
3 may reflect the reciprocal expression of these genes in
the developing hippocampus or the differential expression
observed for adult hippocampal regions (Ernfors et al.,
1990; Maisonpierre et al., 1990). Although multiple effects of
neurotrophins in the nervous system have been elucidated,
their relevance to Hpca-mediated differentiation remains largely
undefined.
Signal transducer and activation of transcription 3 (STAT3)
is a key intermediary in signaling by many cytokines and
growth factor receptors; it is activated by phosphorylation at
Tyr705, thereby inducing dimerization, nuclear translocation
and DNA binding (Henze et al., 1996; Mitchell and John,
2005). STAT3 activation is also regulated by phosphorylation
at Ser727 via the MAPK or mTOR pathway (Park et al.,
2010). STAT3 plays an important role in the differentiation
of neurons in response to neurotrophic factors and growth
factors (Yu et al., 2009). During brain development, activated
STAT3 in conjunction with other cofactors induces expression
of glial fibrillary acidic protein (GFAP) in neural precursor
cells (Bonni et al., 1997; Nakashima et al., 1999; Takizawa
et al., 2001; Wang et al., 2015). In addition, STAT3 signaling
is up-regulated in certain neurodegenerative diseases; for
example, spinal cord microglia and reactive astrocytes
have increased levels of phosphorylated STAT3 (Shibata
et al., 2009). Thus STAT3 activation could be critical for
astrocytic differentiation in hippocampal neural precursor cells
(HNPCs).
In this study, we found that Hpca expression increased
during the differentiation of HNPCs and that overexpression
of Hpca stimulated astrocytic differentiation. Overexpression
of Hpca also increased the expression of proneural bHLH
transcription factors and neurotrophins. In contrast, Hpca
deficiency decreased GFAP expression, resulting in defects in
astrogliogenesis with decreased expression of neurotrophins,
reduced numbers of GFAP-positive astrocytes and lower branch
lengths. Furthermore, we found that Hpca specifically promoted




Dulbecco’s modified Eagle medium/Ham’s nutrient mixture F-
12 (DMEM/F-12 1:1 mixture), penicillin/streptomycin solution,
NB (neurobasal medium), human insulin, and B27 were
purchased from Gibco (Grand Island, NY, USA), and bFGF
was from R&D Systems (Minneapolis, MN, USA). S3I-201 was
obtained from Merck Calbiochem/EMD Biosciences (Darmstadt,
Germany). Antibodies used were as follows: NT-3, NT-4/5,
BDNF, Neurogenin 1, β-actin, and GAPDH were from Santa
Cruz Biotechnology (Santa Cruz, CA, USA); p-STAT3 (Ser 727)
and STAT3 were from Cell Signaling Technology (Beverly, MA,
USA); Hpca and NeuroD were from Abcam (Cambridge, UK);
Myc (Bethyl Laboratories, Montgomery, TX, USA); GFAP (Dako,
Glostrup, Denmark); Alexa Fluor R© 488 secondary antibody goat
anti-mouse IgG, Alexa Fluor R© 594 secondary antibody goat
anti-rabbit IgG, and GFP monoclonal antibody were from Life
Technologies (Paisley, UK). All other chemicals were of analytical
grade.
Primary Culture of Hippocampal Neural
Precursor Cells
Pregnant Sprague–Dawley (SD) rats were obtained from Orient
Bio Inc. (Seoul, Korea). Briefly, embryonic hippocampi were
mechanically dissected from E16.5 rat embryos in chilled Hank’s
balanced salt solution (Gibco), seeded at 2 × 105 cells on 10-cm
culture dishes (Nunc A/S, Roskilde, Denmark) precoated with
15 µg/ml poly-L-ornithine (Sigma-Aldrich, St Louis, Mo, USA)
and 1 µg/ml fibronectin (Invitrogen, Carlsbad, CA, USA), then
cultured for 4 days in serum-free N2 medium supplemented
with 20 ng/ml bFGF (R&D Systems). The medium was changed
every other day, while the bFGF was supplemented every day
in order to expand the population of proliferative precursors.
For high density cultures, the cells were plated at 4 × 104 cells
per well on coated 24-well plate, 6 × 105 cells per well on
coated 6-well or 1 × 06 cells on coated 6-cm culture dishes.
The plated cells were induced to additional proliferation in
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N2+bFGF up to 70–80% cell confluence, before induction of
differentiation.
Immunofluorescence Staining
Cells were fixed with 4% (w/v) paraformaldehyde in phosphate-
buffered saline (PBS) for 20 min followed by washing with
0.1% BSA in PBS three times at room temperature. They
blocked with 10% normal goat serum in 0.1% BSA in PBS
containing 0.3% Triton X-100 for 1 h at room temperature.
Next, the cells were immunostained with following primary
antibodies; 1:400 rabbit polyclonal anti-GFAP (Dako), and 1:400
mouse monoclonal anti-GFP (Life Technologies) at 4◦C. Cells
were then labeled with 1:2000 Alexa Fluor R© 488 secondary
antibody goat anti-mouse IgG (Life Technologies), and 1:2000
Alexa Fluor R© 594 secondary antibody goat anti-rabbit IgG (Life
Technologies) for 1 h, before mounting in Vectashield (Vector
Laboratories, Burlingame, CA, USA) with 4, 6-diamidino-2-
phenylindole (DAPI) mounting medium. Immunoreactive cells
were analyzed under an epifluorescence microscope (Nikon
Instruments, Melville, NY, USA) at magnifications varying from
×200 to×400.
Transient Transfection of HNPCs
Transfection of HNPCs was carried with the Amaxa
Nucleofector R© Kit V (Amaxa Biosystems, Köln, Germany)
according to the manufacturer’s optimized protocol. In brief,
HNPCs were dissociated using 0.05% trypsin for 5 min followed
by the addition of 10% FBS in N2 medium. The resuspended cells
were counted using a hemocytometer and 5 × 106 cells aliquots
were placed in separate tubes (1 tube per nucleofection). The
cells were centrifuged at 1000 rpm for 5 min and resuspended
in 100 µl of pre-warmed Amaxa Nucleofector Solution. Each
100 µl of cell suspension was mixed with either 10 µg each of
pMSCV-IRES-EGFP or pMSCV-Hpca-myc-IRES-EGFP. These
DNA-cell suspensions were immediately transferred to Amaxa
certified cuvettes and electroporated using the Nucleofector
program G-13. The samples were examined by RT-PCR and
western blot [see below].
RNA Interference
For Hpca or Stat3 silencing experiments, Hpca siRNA (ON-
TARGET plus SMART pool), and negative control siRNA
(ON-TARGET plus non-targeting pool) were purchased
from Dharmacon (Lafayette, CO, USA). Stat3 siRNA (5′-
CUGUCUUUAGGCUGAUCAU-3′) was purchased from
Bioneer (Daejeon, Korea). Transient siRNA transfections
were performed in 6-well plates; cells were transfected with
Lipofectamine RNAiMAX (Invitrogen) and 100 nM siRNA
according to the manufacturer’s protocol (Invitrogen); and cells
were harvested 72 h later.
Virus Construction and Transduction
Hippocalcin cDNA was cloned into a retrovirus vector containing
IRES-EGFP (obtained from Dr. Hee Yong Chung, Department
of Biomedical Science, Graduate School of Biomedical Science
and Engineering, Hanyang University, Seoul, Republic of Korea).
Virus particles were produced by transfecting the retrovirus
packaging cell line 293gpg with the vector using Lipofectamine
(Invitrogen), and supernatants containing viral particles were
harvested after incubation for 48 h. For virus transduction,
prepared HNPCs were incubated with a viral suspension
(4 × 106 particles/ml) containing polybrene (1 µg/ml; Sigma-
Aldrich) for 4 h, followed by transfer to bFGF-supplemented N2
medium.
Real-Time PCR and RT (Reverse
Transcription)-PCR
cDNA was prepared from total mRNA extracted from cells
with TRIzol R© reagent (Thermo Fisher Scientific Inc., Waltham,
MA, USA); 1 µg samples of RNA was reverse-transcribed using
Superscript II and random primers (Invitrogen). The resulting
cDNA was amplified by PCR using the primers listed in Table 1.
PCR products were analyzed on 1.5% agarose gels and stained
with loading star (Dyne Bio, Seoul, Korea). For real-time PCR,
5 µl of RT reaction product was amplified in triplicate in a final
volume of 20 µl iQTM SYBR R© Green supermix (Bio-Rad, CA,
TABLE 1 | Primers used for RT-PCR.
Gene symbol Primer sequences (5′→3′) Annealing Temp (◦C) Cycles PCR product size (bp)
Hippocalcin (Hpca) ATGGGCAAGCAGAATAGCAAG 56 30 582
TCAGAACTGGGAAGCGCTGCT
Nt3 GGTCAGAATTCCAGCCGATGA 55 32 515
GGCACACACACAGGAAGTGTC
Nt4/5 CCCTGCGTCAGTACTTCTTCGAGAC 55 32 249
CTGGACGTCAGGCACGGCCTGTTC
Bdnf GTGACAGTATTAGCGAGTGGG 56 28 213
GGGTAGTTCGGCATTGC
NeuroD CTCAGTTCTCAGGACGAGGA 58 32 368
TAGTTCTTGGCCAAGCGCAG
Ngn1 ATGCCTGCCCCTTTGGAGAC 55 32 320
TGCATACGGTTGCGCTCGC
Gapdh GGCATTGCTCTCAATGACAA 60 25 165
AGGGCCTCTCTCTTGCTCTC
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FIGURE 1 | Effect of Hippocalcin (Hpca) on GFAP expression during differentiation of HNPCs. (A,B) HNPCs were induced to differentiate by withdrawal of
bFGF. (A) After 48 h, mRNA levels of Hpca and Gfap were determined by real-time PCR. ∗p < 0.001 compared with the +bFGF control. 20 µg aliquots of protein
were analyzed by western blotting with anti-hippocalcin, anti-GFAP, and anti-GAPDH. (B) The cells were stained with anti-GFAP (red). Bar, 100 µm. (C–E) Cells were
transfected with pMSCV-IRES-EGFP or pMSCV-Hpca-myc-IRES-EGFP for 48 h and then incubated for 24 h after removal of bFGF. The mRNA levels of neurotro-
phins and proneural bHLH transcription factors were analyzed by RT-PCR (C) and real-time PCR (D). Data are means ± SD of three independent experiments.
∗p < 0.05; ∗∗p < 0.01 compared with the +bFGF/vector control. (E) Proteins were analyzed by western blotting with anti-Myc, anti-NT-3, anti-NT-4/5, anti-BDNF,
(Continued)
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FIGURE 1 | Continued
anti-NeuroD, anti-Neurogenin 1, and anti-GAPDH. Graph shows mean
densities as fold increases in three independent experiments (mean ± SD).
Band intensities were quantified with Quantity Ones software. ∗p < 0.05;
∗∗p < 0.01 compared with the +bFGF/vector control. (F) HNPCs were
transduced with EGFP vector or Hpca-myc-EGFP for 48 h and induced to
differentiate by withdrawal of bFGF. After differentiation for 72 h, fixed cells
were immunostained with anti-GFP (green) and anti-GFAP (red). GFP-stained
cells fluoresce green, and GFAP-stained cells fluoresce red, while cells stained
with both GFP and GFAP fluoresce yellow. Bar, 100 µm. (G) Graph shows
the percentages of GFAP-positive cells. GFAP-positive cells among GFP-
positive cells were counted under a fluorescence microscopy. The proportions
of GFAP-positive cells were determined in randomly selected areas from
five cultures (means ± SD). ∗p < 0.001 compared with the +bFGF/vector
control. ∗∗p < 0.001 compared with the –bFGF/vector control. (H) Branch
lengths were measured in random areas from five cultures (means ± SD).
∗p < 0.01 compared with the +bFGF/vector control. ∗∗p < 0.01 compared
with the –bFGF/vector control.
USA). The primer sequences for real-time PCR were the same
as for RT-PCR.
Western Blot Analysis
Cells were lysed in 20 mM Tris–HCl (pH 7.5) containing
150 mM NaCl, 1 mM EDTA, 1 mM EGTA, 2.5 mM
sodium pyrophosphate, 1% Triton X-100, 1 mM PMSF, and
1 mM Na3VO4. Protein samples (20–30 µg) were loaded
onto SDS–polyacrylamide gels and transferred to nitrocellulose
membranes (Amersham Pharmacia Biotech, Amersham, UK)
after electrophoresis. After blocking with 5% non-fat dried
milk for 1 h, membranes were incubated with primary
antibodies against Hpca anti-rabbit (1:500; Abcam), Myc anti-
rabbit (1:2000; Bethyl Laboratories), NT-3 anti-rabbit (1:200;
Santa Cruz Biotechnology), NT-4/5 anti-rabbit (1:200; Santa
Cruz Biotechnology), BDNF anti-rabbit (1:250; Santa Cruz
Biotechnology), NeuroD anti-rabbit (1:500; Abcam), Neurogenin
1 anti-goat (1:200; Santa Cruz Biotechnology), phospho-
STAT3 anti-rabbit (1:1000; Cell Signaling Technology), STAT3
anti-mouse (1:1000; Cell Signaling Technology), β-actin anti-
mouse (1:1000; Santa Cruz Biotechnology), GAPDH anti-
rabbit (1:1000; Santa Cruz Biotechnology), GFAP anti-mouse
(1:1000; Cell Signaling Technology) followed by HRP-conjugated
secondary antibody (1:2000; New England Biolabs, Beverly,
MA, USA), and specific bands were detected by ECL (Thermo
Scientific, Rockford, IL, USA). Bands were quantified using
ImageJ (v1.46r, National Institutes of Health, Bethesda, MA,
USA).
Cell Counting and Measurement of
Branch Outgrowth
Cell counting was performed in microscopic field, using an
eyepiece grid at a final magnification of 200× or 400×.
Immunostained and DAPI-stained cells were counted in 5–
10 random areas of each culture coverslip. All values were
confirmed in at least five independent cultures. Photos of
the cells were taken with an epifluorescence microscope
(Nikon Instruments), and morphological characteristics were
quantitated using Image J software (NIH1). The length of
branches was defined as the distance from the cell body
(proximal) to the tip of the longest branch (distal). For each
graph, data on branch length were generated from at least
five independent sets of astrocytes (in each condition) and
greater than 100 cells were counted for each condition in each
experiment.
Statistical Analysis
Quantitative data are expressed as means ± SD of three to
five independent experiments. The statistical significance of
differences between groups was analyzed using Student’s t-test
and was considered significant at p< 0.05.
RESULTS
Hpca is Required for Glial Fibrillary
Acidic Protein (GFAP) Expression during
Differentiation of HNPCs
Dissected and mechanically dissociated cells from hippocampi of
E16.5 rat embryos were used to isolate NPCs. For growth of these
cells, fresh bFGF (20 ng/ml) was present to prevent differentiation
and promote proliferation. To investigate the role of Hpca
in HNPCs differentiation, bFGF was removed for 48 h. We
initially performed real-time PCR analyses and western blotting
to determine the mRNA expression and protein level of Hpca.
As shown in Figure 1A, Hpca and Gfap expression increased
in differentiating cultures. When the cells were immunostained
with GFAP, we also observed significantly increased GFAP
positive cells during differentiation (Figure 1B). Increased levels
of nerve-growth factors such as NT-3, NT-4/5, and BDNF,
together with the proneural bHLH transcription factors neuroD
and Ngn1 have been detected in the developing and adult
hippocampus and they have major roles in development and
maintenance of the hippocampal formation (Ip et al., 1993).
Since these factors are closely associated with neural precursor
cell differentiation, they can be used as markers of this process
(Markus et al., 2002). To examine the effect of Hpca on
differentiation, either pMSCV-IRES-EGFP or pMSCV-Hpca-
myc-IRES-EGFP was transfected into the HNPCs for 2 days, and
then cells were induced differentiation for 1 day. We showed that
mRNA levels (Figures 1C,D) and protein expression (Figure 1E)
of NT-3, NT-4/5, BDNF, NeuroD, and Ngn1 were significantly
increased by Hpca overexpression in the presence of bFGF
compared with vector control in the presence of bFGF. HNPCs
have been considered as the primary progenitor cells for the
neuronal and glial cell lineages during development (Rietze et al.,
2001). Therefore, we examined the role of Hpca in expression
of neuronal and glial markers during differentiation. HNPCs
were transduced with either pMSCV-IRES-EGFP or pMSCV-
Hpca-myc-IRES-EGFP for 2 days and allowed to differentiate
for 3 days. We measured the percentage of GFAP-positive
cells and Tuj1-positive cells under a fluorescence microscope.
1http://rsb.Info.nih.gov/ij/
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As shown in Figures 1F,G, Hpca overexpression resulted in
markedly enhanced GFAP-positive astrocytes compared with
vector control in the presence or absence of bFGF in HNPCs; at
the same time Tuj1-positve neurons were not altered (data not
shown). Moreover, Hpca overexpression significantly increased
the length of branches compared with vector control under the
either with bFGF or withdrawal bFGF (Figures 1F,H). We also
found that overexpression of Hpca increased protein levels of
GFAP compared with vector control in the presence or absence
of bFGF in HNPCs (Supplementary Figure 1). These findings
collectively imply that Hpca, which regulates the expression
of neurotrophins and proneural bHLH transcription factors,
promotes astrocytic differentiation of HNPCs.
Knockdown of Hpca Suppresses the
Astrocytic Differentiation of HNPCs
To confirm the role of Hpca in the expression of GFAP,
we examined the effects of Hpca knockdown. 3 days after
transfection of HNPCs with Hpca siRNA, the cells were allowed
to differentiate for 1 day, and Hpca expression was examined
by western blotting. As shown in Figure 2A, Hpca siRNA
markedly decreased expression of GFAP. We also found that
knockdown of Hpca decreased expression of NT-3, NT-4/5,
BDNF, NeuroD, and Ngn1 in the absence of bFGF in HNPCs
(Figures 2B,C). To confirm the effect of Hpca on astrocytic
differentiation and branch outgrowth of HNPCs, either control
siRNA or Hpca siRNA was transfected into the HNPCs for
3 days. Similarly, as shown in Figures 2D,E, it reduced the
number of GFAP-positive cells as well as branch outgrowth
(Figures 2D,F).
Taken together, these results indicate that Hpca is crucial for
the expression of GFAP and for branch formation.
Hpca Increases Activation of Stat3
(Ser727) in Hnpcs
We next asked which signaling pathway was responsible for
Hpca-mediated astrocytic differentiation of HNPCs. Because
the STAT3 activation is associated with GFAP expression in
neural precursor cells (Sun et al., 2001), we investigated whether
STAT3 was phosphorylated by Hpca overexpression. As shown
FIGURE 2 | Effect of Hpca downregulation on astrocytic differentiation of HNPCs. (A–C) HNPCs were transfected with control siRNA or Hpca siRNA for
72 h and induced to differentiate by removal of bFGF for 24 h. (A) Cells were lysed and analyzed by western blotting with anti-hippocalcin, anti-GFAP, and
anti-GAPDH. Graph shows mean densities as fold increases in three independent experiments (means ± SD). Band intensities were quantified with Quantity Ones R©
software. ∗p < 0.05 compared with the -bFGF/control siRNA. The mRNA levels of neurotrophins and proneural bHLH transcription factors were analyzed by RT-PCR
(B) and real-time PCR (C). Data are means ± SD of three independent experiments. ∗p < 0.05; ∗∗p < 0.01 compared with the -bFGF/control siRNA. (D) Cells were
transiently transfected with control siRNA or Hpca siRNA for 72 h and induced to differentiate by withdrawal of bFGF. After differentiation for 72 h, fixed cells were
stained for immunocytochemical analysis of an astrocyte marker (GFAP, red) and anti-DAPI (blue). Bar, 100 µm. The boxed area is magnified and the arrow indicates
magnified cells. (E,F) The number of GFAP-positive cells and total cells were counted and branch lengths were measured in randomly selected areas from five
cultures (means ± SD). ∗p < 0.05; ∗∗p < 0.001 compared with the -bFGF/control siRNA.
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FIGURE 3 | Effect of Hpca on STAT3 (Ser727) activation in HNPCs. (A) HNPCs were transfected with pMSCV-IRES-EGFP or pMSCV-Hpca-myc-IRES-EGFP
for 48 h in the presence of bFGF. Proteins were analyzed by western blotting with anti-Myc, anti-p-STAT3 (Ser727), anti-STAT3, and anti-β-actin. (B) Graph shows
mean densities as fold increases in three independent experiments (means ± SD). Band intensities were quantified with Quantity Ones R© software. ∗p < 0.001
compared with the vector control. (C) Cells were transfected with control siRNA or Hpca siRNA for 72 h. Cell were lysed and analyzed by western blotting with
anti-hippocalcin, anti-p-STAT3 (Ser727), anti-STAT3, and anti-β-actin. (D) Graph shows mean densities as fold increases from three independent experiments
(means ± SD). ∗p < 0.001 compared with the +bFGF/control siRNA.
in Figures 3A,B, phosphorylation of STAT3 at Ser727 was
significantly increased by overexpression of Hpca compared
to vector control in HNPCs. On the other hand, knockdown
of Hpca decreased the phosphorylation of STAT3 (Ser727)
(Figures 3C,D). These results suggest that Hpca has an important
role in the activation of STAT3 (Ser727) during astrocytic
differentiation of HNPCs.
Inhibition of STAT3 (Ser727) Activation
Reduces Astrocytic Differentiation of
HNPCs
Next, we determined whether STAT3 (Ser727) activation is
required for astrocytic differentiation of HNPCs. Cells were
transiently transfected with pMSCV-IRES-EGFP or pMSCV-
Hpca-myc-IRES-EGFP for 2 days and treated with the STAT3
inhibitor, S3I-201, for 1 day. Inhibition of STAT3 not only
decreased phosphorylation of STAT3 (Ser727) (Figures 4A,B)
but also reduced the level of GFAP (Figures 4A,C) and
transcript levels of NT-3, NT-4/5, BDNF, NeuroD, and Ngn1
(Figures 4D,E). We also found that treatment with 10 µM
S3I-201 significantly reduced the number of GFAP-positive
cells (31.8 ± 1.8% vs. 16.3 ± 1.3%, p < 0.05; Figures 4F,G)
compared to the overexpression of Hpca. To test if STAT3 can
also promote the branch outgrowth, we calculated the length
of branches. The extent of branch outgrowth observed upon
overexpression of Hpca was also reduced when STAT3 was
inhibited (Figures 4F,H). To further determine the involvement
of STAT3 in Hpca-mediated astrocytic differentiation, we
knocked down STAT3 using siRNA. Stat3 siRNA completely
abolished expression of GFAP (Figures 5A,B) and transcripts
of NT-3, NT-4/5, BDNF, NeuroD, and Ngn1 compared with
overexpression of Hpca (Figures 5C,D). We also found
that knockdown of STAT3 markedly decreased the number
of GFAP-positive cells (45.0 ± 4.0% vs. 15.0 ± 1.0%,
p < 0.05; Figures 5E,F) compared with overexpression of Hpca.
Furthermore, knockdown of STAT3 decreased branch outgrowth
(Figure 5G). Taken together, our results demonstrate that STAT3
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FIGURE 4 | Inhibitory effect of STAT3 (Ser727) activation on astrocytic differentiation of HNPCs. (A) HNPCs were transfected with pMSCV-IRES-EGFP or
pMSCV-Hpca-myc-IRES-EGFP for 48 h and then treated with 10 µM S3I-201 for 24 h. Cells were lysed and analyzed by western blotting with anti-Myc,
anti-p-STAT3 (Ser727), anti-STAT3, anti-GFAP, and anti-β-actin. (B,C) Graphs show mean densities as fold increases from three independent experiments
(means ± SD). Band intensities were quantified with Quantity Ones R© software. ∗p < 0.01 compared with the Hpca/DMSO. (D,E) Cells were transfected with
pMSCV-IRES-EGFP or pMSCV-Hpca-myc-IRES-EGFP for 48 h and then treated with 10 µM S3I-201 for 24 h. mRNA levels of neurotrophins and proneural bHLH
transcription factors were measured by RT-PCR (D) and real-time PCR (E). Graph shows mean densities as fold increases in three independent experiments
(means ± SD). ∗p < 0.05; ∗∗p < 0.01 compared with the Hpca/DMSO. (F) Cells were transduced with EGFP vector or Hpca-myc-EGFP for 48 h and then treated
with 10 µM S3I-201 for 24 h. Fixed cells were immunostained with anti-GFP (green) and anti-GFAP (red). Bar, 100 µm. The boxed area is magnified and the arrow
indicates magnified cells. (G,H) GFAP-positive cells were counted under a fluorescence microscopy and branch lengths were measured in randomly selected areas
from five cultures. Data are means ± SD of five values. ∗p < 0.05; ∗∗p < 0.001 compared with the Hpca/DMSO.
is the signaling molecule that triggers branch outgrowth leading
to astrocytic differentiation of HNPCs.
DISCUSSION
The objective of this study was to elucidate the role of Hpca
in neural precursor cell differentiation during hippocampal
development. Differentiation of HNPCs was accompanied by
upregulation of Hpca expression, and experiments involving gain
or loss of Hpca function argued that Hpca was important for the
differentiation process. Development of the mammalian nervous
system is fulfilled through precursor cells that sequentially
generate neurons and glial cells (Luskin et al., 1988; Price
and Thurlow, 1988; Walsh and Cepko, 1988; Davis and
Temple, 1994). In vivo, cortical neurogenesis occurs during
embryogenesis, while gliogenesis largely occurs postnatally.
Remarkably, this precisely timed process can be reproduced
in isolated embryonic cortical stem cells (Qian et al., 2000;
Ross et al., 2003; Miller and Gauthier, 2007). Therefore,
a major question is how the fates of neural precursors
are switched from neurogenesis in the earlier stages to
gliogenesis later. One possible explanation is that the precursor
cells themselves could change, for example, in response to
neurogenic factors (Nieto et al., 2001; Sun et al., 2001;
Menard et al., 2002; He et al., 2005), or growth factors
(Sauvageot and Stiles, 2002). Here, we found that Hpca
controlled the competence of precursors to differentiate into
astrocytes by regulating the expression of proneural bHLH
transcription factors and neurotrophins that induce GFAP
expression in HNPCs. To our knowledge, this is the first
example in which Hpca promoted differentiation toward a
specific lineage, and particularly, toward astrocytes during
development.
Hippocalcin has an important role in AMPAR-mediated
endocytosis and NMDAR-mediated hippocampal LTD (Palmer
et al., 2005), and its expression is involved in synapse formation
and age-related postsynaptic function (Furuta et al., 1999). We
have reported that it is one of the major regulatory proteins in the
Ca2+-mediated PLD signaling pathway (Oh et al., 2006) and that
it induces neurite outgrowth leading to neuronal differentiation
in H19-7 cells (Oh et al., 2008). However, its involvement in
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FIGURE 5 | Effect of STAT3 downregulation on astrocytic differentiation of HNPCs. (A) HNPCs were transfected with pMSCV-IRES-EGFP or
pMSCV-Hpca-myc-IRES-EGFP for 48 h and then transfected with control siRNA or Stat3 siRNA for 72 h. Proteins were analyzed in western blotting with anti-Myc,
anti-p-STAT3 (Ser727), anti-STAT3, anti-GFAP, and anti-GAPDH. (B) Graph shows mean densities as fold increases from three independent experiments
(means ± SD). ∗p < 0.01 compared with Hpca/control siRNA. (C,D) mRNA levels of neurotrophins and proneural bHLH transcription factors were analyzed by
RT-PCR (C) and real-time PCR (D). Data are means ± SD of three independent experiments. ∗p < 0.05; ∗∗p < 0.01 compared with Hpca/control siRNA. (E) Cells
were transduced with EGFP vector or Hpca-myc-EGFP for 48 h and then transfected with control siRNA or Stat3 siRNA for 72 h. Fixed cells were immunostained
with anti-GFP (green) and anti-GFAP (red). Bar, 100 µm. (F) Graph shows the percentages of GFAP-positive cells. GFAP-positive cells among GFP-positive cells
were counted under fluorescence microscopy. The proportions of GFAP-positive cells were determined in randomly selected areas from five cultures (means ± SD).
∗p < 0.05 compared with the Hpca/control siRNA. (G) Branch lengths were measured in randomly selected areas from five cultures (means ± SD). ∗p < 0.05
compared with the Hpca/control siRNA.
astrocytic differentiation has not been studied. In this study, we
found that expression of neurotrophins and proneural bHLH
transcription factors are regulated by Hpca-mediated activation
of STAT3 (Ser727), which leads to branch outgrowth and
astrocytic differentiation in HNPCs. Several studies have reported
that expression of neurotrophins was increased in cultured rat
hippocampal astrocytes and astrocytes showed expression of
neurotrophin receptors. However, the ability of neurotrophins
to induce astrocytic differentiation and the effect of proneural
bHLH transcription factors on astrocytic differentiation has not
been studied. Thus, we will investigate whether Hpca-mediated
expression of neurotrophins and proneural bHLH transcription
factors has effect on astrocytic differentiation of HNPCs in
further study.
The determination of neuronal/glial fate during CNS
development involves complex interactions between intrinsic
signals acting through many transcription factors (Edlund
and Jessell, 1999). Above all, STAT3 plays essential roles in
determining the fate of neural stem cells (NSCs) (Han et al.,
2006). Inhibition of STAT3 enhances the differentiation of
human NSCs to motor neurons and reduces astrocytosis,
and similarly, induces neurogenesis and inhibits gliogenesis
(Gu et al., 2005; Cao et al., 2010; Natarajan et al., 2014).
Previous studies have shown that GFAP expression in neural
precursor cells is dependent on the activation of STAT3
(Bonni et al., 1997; Nakashima et al., 1999; Takizawa et al.,
2001; Herrmann et al., 2008). Interestingly, we found that
Hpca enhanced STAT3 (Ser727) activation, but did not
cause any phosphorylation at Tyr705 (data not shown).
Furthermore, inhibition of STAT3 activation by Stat3 siRNA
or STAT3 inhibitor decreased transcripts of neurotrophins and
proneural bHLH transcription factors and GFAP expression
induced by Hpca overexpression, indicating that Hpca-
mediated STAT3 (Ser727) activation is essential for astrocytic
differentiation. Our results are consistent with earlier reports
in which suppression or conditional deletion of STAT3
inhibited glial differentiation (Sun et al., 2001; Gu et al.,
2005; Natarajan et al., 2014). However, the kinase involved
in Hpca-mediated STAT3 activation remains to be identified.
Interestingly, the STAT3 inhibitor and Stat3 siRNA in our
Frontiers in Molecular Neuroscience | www.frontiersin.org 9 October 2016 | Volume 9 | Article 110
fnmol-09-00110 October 26, 2016 Time: 13:44 # 10
Kang et al. The Role of Hippocalcin in Astrocytic Differentiation
experiments completely inhibit the expression of neurotrophins
and proneural bHLH transcription factors. Recent studies have
shown that the activities of STAT family proteins can be
modulated by interactions with other DNA-binding sites; for
instance, STAT3 interacts with c-Jun, c-Fos and the CREB-
binding protein co-activators (Zhang et al., 1999; Coqueret and
Gascan, 2000). Although the mechanisms underlying this process
have not been fully elucidated, our findings offer a theoretical
basis for how astrocytic differentiation of HNPCs is regulated.
Taken together, the present study provides the first evidence
that Hpca promotes gliogenesis in HNPCs, and induces GFAP
expression and branch outgrowth by activating STAT3 (Ser727).
Gliogenesis is tightly controlled because of its critical importance
in proper physiological function, and multiple signal pathways
control the growth and directionality of the relevant cell-fate
decision. Recent work has demonstrated abnormalities in the
signaling pathways responsible for gliogenesis and neurogenesis
could contribute to the pathogenesis of neurodegenerative
diseases and tumor development within the nervous system
(Lee et al., 2000; Shors, 2004). Recognition of the regulatory
mechanisms of gliogenesis provides new direction for
intervention of neurogenic disorders. Furthermore, Hpca
is implicated in memory formation, neuronal excitability
(Kobayashi et al., 2012) and Hpca knockout mice have a defect
in spatial and associative memory (Kobayashi et al., 2005). It is
possible that Hpca plays an important role in neural plasticity and
memory function and further studies should address its possible
use as a marker of neurodegenerative disorder and for promoting
glial cell generation in vivo.
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